Cargando…
Reformulating Tylocrebrine in Epidermal Growth Factor Receptor Targeted Polymeric Nanoparticles Improves Its Therapeutic Index
[Image: see text] Several promising anticancer drug candidates have been sidelined owing to their poor physicochemical properties or unfavorable pharmacokinetics, resulting in high overall cost of drug discovery and development. Use of alternative formulation strategies that alleviate these issues c...
Autores principales: | Kirtane, Ameya R., Wong, Henry L., Guru, Bharath Raja, Lis, Lev G., Georg, Gunda I., Gurvich, Vadim J., Panyam, Jayanth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2015
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525301/ https://www.ncbi.nlm.nih.gov/pubmed/26065924 http://dx.doi.org/10.1021/acs.molpharmaceut.5b00173 |
Ejemplares similares
-
Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer
por: Khanna, Vidhi, et al.
Publicado: (2019) -
Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy
por: Arora, Sumit, et al.
Publicado: (2014) -
Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors
por: Song, Jung Min, et al.
Publicado: (2016) -
Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling
por: Song, Jung Min, et al.
Publicado: (2017) -
Portugal’s voluntary food reformulation agreement and the WHO reformulation targets
por: Goiana-da-Silva, Francisco, et al.
Publicado: (2019)